These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25638764)

  • 41. Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
    Oliver AC; Riva E; Mosquera R; Galeano S; Pierri S; Bello L; Caneiro A; Gai R; Miller A; Muxi P
    Ann Hematol; 2020 Apr; 99(4):877-884. PubMed ID: 32062742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A de-escalation protocol for febrile neutropenia cases and its impact on carbapenem resistance: A retrospective, quasi-experimental single-center study.
    Alshukairi A; Alserehi H; El-Saed A; Kelta M; Rehman JU; Khan FA; Alsalmi H; Alattas M; Aslam M
    J Infect Public Health; 2016; 9(4):443-51. PubMed ID: 26688375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India.
    Aamir M; Abrol P; Sharma D; Punia H
    Trop Doct; 2016 Jul; 46(3):142-8. PubMed ID: 26612093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spectrum of systemic bacterial infections during febrile neutropenia in pediatric oncology patients in tertiary care pediatric center.
    Siddaiahgari S; Manikyam A; Kumar KA; Rauthan A; Ayyar R
    Indian J Cancer; 2014; 51(4):403-5. PubMed ID: 26842136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.
    Bow EJ; Rotstein C; Noskin GA; Laverdiere M; Schwarer AP; Segal BH; Seymour JF; Szer J; Sanche S
    Clin Infect Dis; 2006 Aug; 43(4):447-59. PubMed ID: 16838234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes.
    Sood P; Seth T; Kapil A; Sharma V; Dayama A; Sharma S; Kumar S; Singh AK; Mishra P; Mahapatra M
    J Indian Med Assoc; 2012 Jul; 110(7):439-44. PubMed ID: 23520666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore.
    Jin J; Lee YM; Ding Y; Koh LP; Lim SE; Lim R; Tambyah PA; Hsu LY
    Ann Acad Med Singap; 2010 Jun; 39(6):453-9. PubMed ID: 20625621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients.
    Ram R; Farbman L; Leibovici L; Raanani P; Yeshurun M; Vidal L; Gafter-Gvili A; Peck A; Shpilberg O; Paul M
    Int J Antimicrob Agents; 2012 Aug; 40(2):123-6. PubMed ID: 22727772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.
    Le Guyader N; Auvrignon A; Vu-Thien H; Portier E; Tabone MD; Leverger G
    Support Care Cancer; 2004 Oct; 12(10):720-4. PubMed ID: 15138864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients.
    Ko JH; Kim SH; Kang CI; Cho SY; Lee NY; Chung DR; Peck KR; Song JH
    J Korean Med Sci; 2019 Jan; 34(2):e17. PubMed ID: 30636947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Meropenem therapy in children with febrile neutropenia].
    Müller J; Kovács G; Garami M; Schmidt M; Fekete G
    Orv Hetil; 2003 Oct; 144(43):2115-20. PubMed ID: 14661443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
    Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
    Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
    Roongpoovapatr P; Suankratay C
    J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study.
    Al-Tawfiq JA; Hinedi K; Khairallah H; Saadeh B; Abbasi S; Noureen M; Raza S; Alkhatti A
    J Infect Public Health; 2019; 12(3):364-366. PubMed ID: 30594483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
    Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
    Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
    Figuera Esparza M; Carballo M; Silva M; Figueredo A; Avilán J
    Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics].
    Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S
    Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.